<?xml version='1.0' encoding='utf-8'?>
<document id="30420479"><sentence text="Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine."><entity charOffset="26-38" id="DDI-PubMed.30420479.s1.e0" text="Dolutegravir" /><entity charOffset="43-66" id="DDI-PubMed.30420479.s1.e1" text="Artemether-Lumefantrine" /><entity charOffset="70-92" id="DDI-PubMed.30420479.s1.e2" text="Artesunate-Amodiaquine" /><pair ddi="false" e1="DDI-PubMed.30420479.s1.e0" e2="DDI-PubMed.30420479.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s1.e0" e2="DDI-PubMed.30420479.s1.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s1.e0" e2="DDI-PubMed.30420479.s1.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s1.e1" e2="DDI-PubMed.30420479.s1.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s1.e1" e2="DDI-PubMed.30420479.s1.e2" /></sentence><sentence text="Across sub-Saharan Africa, patients with HIV on antiretrovirals often get malaria and need cotreatment with artemisinin-containing therapies"><entity charOffset="108-119" id="DDI-PubMed.30420479.s2.e0" text="artemisinin" /></sentence><sentence text=" We undertook two pharmacokinetic studies in healthy volunteers, using standard adult doses of artemether-lumefantrine or artesunate-amodiaquine given with 50 mg once daily dolutegravir (DTG) to investigate the drug-drug interaction between artemether-lumefantrine or artesunate-amodiaquine and dolutegravir"><entity charOffset="106-118" id="DDI-PubMed.30420479.s3.e0" text="lumefantrine" /><entity charOffset="122-132" id="DDI-PubMed.30420479.s3.e1" text="artesunate" /><entity charOffset="173-185" id="DDI-PubMed.30420479.s3.e2" text="dolutegravir" /><entity charOffset="187-190" id="DDI-PubMed.30420479.s3.e3" text="DTG" /><entity charOffset="252-264" id="DDI-PubMed.30420479.s3.e4" text="lumefantrine" /><entity charOffset="268-278" id="DDI-PubMed.30420479.s3.e5" text="artesunate" /><entity charOffset="279-290" id="DDI-PubMed.30420479.s3.e6" text="amodiaquine" /><entity charOffset="295-307" id="DDI-PubMed.30420479.s3.e7" text="dolutegravir" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e0" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e1" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e2" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e3" e2="DDI-PubMed.30420479.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e3" e2="DDI-PubMed.30420479.s3.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e3" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e3" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e3" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e4" e2="DDI-PubMed.30420479.s3.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e4" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e4" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e4" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e5" e2="DDI-PubMed.30420479.s3.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e5" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e5" e2="DDI-PubMed.30420479.s3.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e6" e2="DDI-PubMed.30420479.s3.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s3.e6" e2="DDI-PubMed.30420479.s3.e7" /></sentence><sentence text=" The dolutegravir/artemether-lumefantrine interaction was evaluated in a two-way crossover study and measured artemether, dihydroartemisinin, lumefantrine, and desbutyl-lumefantrine over 264 h"><entity charOffset="5-17" id="DDI-PubMed.30420479.s4.e0" text="dolutegravir" /><entity charOffset="29-41" id="DDI-PubMed.30420479.s4.e1" text="lumefantrine" /><entity charOffset="110-120" id="DDI-PubMed.30420479.s4.e2" text="artemether" /><entity charOffset="122-140" id="DDI-PubMed.30420479.s4.e3" text="dihydroartemisinin" /><entity charOffset="142-154" id="DDI-PubMed.30420479.s4.e4" text="lumefantrine" /><entity charOffset="160-181" id="DDI-PubMed.30420479.s4.e5" text="desbutyl-lumefantrine" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e0" e2="DDI-PubMed.30420479.s4.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e1" e2="DDI-PubMed.30420479.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e1" e2="DDI-PubMed.30420479.s4.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e1" e2="DDI-PubMed.30420479.s4.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e1" e2="DDI-PubMed.30420479.s4.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e1" e2="DDI-PubMed.30420479.s4.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e2" e2="DDI-PubMed.30420479.s4.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e2" e2="DDI-PubMed.30420479.s4.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e2" e2="DDI-PubMed.30420479.s4.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e2" e2="DDI-PubMed.30420479.s4.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e3" e2="DDI-PubMed.30420479.s4.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e3" e2="DDI-PubMed.30420479.s4.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e3" e2="DDI-PubMed.30420479.s4.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e4" e2="DDI-PubMed.30420479.s4.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s4.e4" e2="DDI-PubMed.30420479.s4.e5" /></sentence><sentence text=" The dolutegravir/artesunate-amodiaquine interaction was investigated using a parallel study design due to long half-life of the amodiaquine metabolite, desethylamodiaquine and measured artesunate, amodiaquine, and desethylamodiaquine over 624 h"><entity charOffset="5-17" id="DDI-PubMed.30420479.s5.e0" text="dolutegravir" /><entity charOffset="18-28" id="DDI-PubMed.30420479.s5.e1" text="artesunate" /><entity charOffset="29-40" id="DDI-PubMed.30420479.s5.e2" text="amodiaquine" /><entity charOffset="129-140" id="DDI-PubMed.30420479.s5.e3" text="amodiaquine" /><entity charOffset="153-172" id="DDI-PubMed.30420479.s5.e4" text="desethylamodiaquine" /><entity charOffset="186-196" id="DDI-PubMed.30420479.s5.e5" text="artesunate" /><entity charOffset="198-209" id="DDI-PubMed.30420479.s5.e6" text="amodiaquine" /><entity charOffset="215-234" id="DDI-PubMed.30420479.s5.e7" text="desethylamodiaquine" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e0" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e1" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e2" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e3" e2="DDI-PubMed.30420479.s5.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e3" e2="DDI-PubMed.30420479.s5.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e3" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e3" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e3" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e4" e2="DDI-PubMed.30420479.s5.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e4" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e4" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e4" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e5" e2="DDI-PubMed.30420479.s5.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e5" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e5" e2="DDI-PubMed.30420479.s5.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e6" e2="DDI-PubMed.30420479.s5.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s5.e6" e2="DDI-PubMed.30420479.s5.e7" /></sentence><sentence text=" Noncompartmental analysis was performed, and geometric mean ratios and 90% confidence intervals were generated for evaluation of both interactions" /><sentence text=" Dolutegravir did not significantly change the maximum concentration in plasma, the time to maximum concentration, and the area under the concentration-time curve (AUC) for artemether, dihydroartemisinin, lumefantrine, and desbutyl-lumefantrine, nor did it significantly alter the AUC for artesunate, dihydroartemisinin, amodiaquine, and desethylamodiaquine"><entity charOffset="1-13" id="DDI-PubMed.30420479.s7.e0" text="Dolutegravir" /><entity charOffset="173-183" id="DDI-PubMed.30420479.s7.e1" text="artemether" /><entity charOffset="185-203" id="DDI-PubMed.30420479.s7.e2" text="dihydroartemisinin" /><entity charOffset="205-217" id="DDI-PubMed.30420479.s7.e3" text="lumefantrine" /><entity charOffset="223-244" id="DDI-PubMed.30420479.s7.e4" text="desbutyl-lumefantrine" /><entity charOffset="289-299" id="DDI-PubMed.30420479.s7.e5" text="artesunate" /><entity charOffset="301-319" id="DDI-PubMed.30420479.s7.e6" text="dihydroartemisinin" /><entity charOffset="321-332" id="DDI-PubMed.30420479.s7.e7" text="amodiaquine" /><entity charOffset="338-357" id="DDI-PubMed.30420479.s7.e8" text="desethylamodiaquine" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e0" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e1" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e2" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e3" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e4" e2="DDI-PubMed.30420479.s7.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e4" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e4" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e4" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e4" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e5" e2="DDI-PubMed.30420479.s7.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e5" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e5" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e5" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e6" e2="DDI-PubMed.30420479.s7.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e6" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e6" e2="DDI-PubMed.30420479.s7.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e7" e2="DDI-PubMed.30420479.s7.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s7.e7" e2="DDI-PubMed.30420479.s7.e8" /></sentence><sentence text=" Coadministration of dolutegravir with artemether-lumefantrine resulted in a 37% decrease in DTG trough concentrations"><entity charOffset="21-33" id="DDI-PubMed.30420479.s8.e0" text="dolutegravir" /><entity charOffset="50-62" id="DDI-PubMed.30420479.s8.e1" text="lumefantrine" /><entity charOffset="93-104" id="DDI-PubMed.30420479.s8.e2" text="DTG" /><pair ddi="false" e1="DDI-PubMed.30420479.s8.e0" e2="DDI-PubMed.30420479.s8.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s8.e0" e2="DDI-PubMed.30420479.s8.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s8.e0" e2="DDI-PubMed.30420479.s8.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s8.e1" e2="DDI-PubMed.30420479.s8.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s8.e1" e2="DDI-PubMed.30420479.s8.e2" /></sentence><sentence text=" Coadministration of dolutegravir with artesunate-amodiaquine resulted in 42 and 24% approximate decreases in the DTG trough concentrations and the AUC, respectively"><entity charOffset="21-33" id="DDI-PubMed.30420479.s9.e0" text="dolutegravir" /><entity charOffset="39-49" id="DDI-PubMed.30420479.s9.e1" text="artesunate" /><entity charOffset="50-61" id="DDI-PubMed.30420479.s9.e2" text="amodiaquine" /><entity charOffset="114-124" id="DDI-PubMed.30420479.s9.e3" text="DTG" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e0" e2="DDI-PubMed.30420479.s9.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e0" e2="DDI-PubMed.30420479.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e0" e2="DDI-PubMed.30420479.s9.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e0" e2="DDI-PubMed.30420479.s9.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e1" e2="DDI-PubMed.30420479.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e1" e2="DDI-PubMed.30420479.s9.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e1" e2="DDI-PubMed.30420479.s9.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e2" e2="DDI-PubMed.30420479.s9.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s9.e2" e2="DDI-PubMed.30420479.s9.e3" /></sentence><sentence text=" The significant decreases in DTG trough concentrations with artemether-lumefantrine and artesunate-amodiaquine and dolutegravir exposure with artesunate-amodiaquine are unlikely to be of clinical significance since the DTG trough concentrations were above dolutegravir target concentrations of 300 ng/ml"><entity charOffset="72-84" id="DDI-PubMed.30420479.s10.e0" text="lumefantrine" /><entity charOffset="89-99" id="DDI-PubMed.30420479.s10.e1" text="artesunate" /><entity charOffset="100-111" id="DDI-PubMed.30420479.s10.e2" text="amodiaquine" /><entity charOffset="116-128" id="DDI-PubMed.30420479.s10.e3" text="dolutegravir" /><entity charOffset="143-153" id="DDI-PubMed.30420479.s10.e4" text="artesunate" /><entity charOffset="154-165" id="DDI-PubMed.30420479.s10.e5" text="amodiaquine" /><entity charOffset="257-269" id="DDI-PubMed.30420479.s10.e6" text="dolutegravir" /><entity charOffset="30-41" id="DDI-PubMed.30420479.s10.e7" text="DTG" /><entity charOffset="220-231" id="DDI-PubMed.30420479.s10.e8" text="DTG" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e7" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e7" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e0" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e1" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e2" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e3" e2="DDI-PubMed.30420479.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e3" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e3" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e3" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e3" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e4" e2="DDI-PubMed.30420479.s10.e4" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e4" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e4" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e4" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e5" e2="DDI-PubMed.30420479.s10.e5" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e5" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e5" e2="DDI-PubMed.30420479.s10.e6" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e8" e2="DDI-PubMed.30420479.s10.e8" /><pair ddi="false" e1="DDI-PubMed.30420479.s10.e8" e2="DDI-PubMed.30420479.s10.e6" /></sentence><sentence text=" Study drugs were well tolerated with no serious adverse events" /><sentence text=" Standard doses of artemether-lumefantrine and artesunate-amodiaquine should be used in patients receiving dolutegravir"><entity charOffset="30-42" id="DDI-PubMed.30420479.s12.e0" text="lumefantrine" /><entity charOffset="47-57" id="DDI-PubMed.30420479.s12.e1" text="artesunate" /><entity charOffset="58-69" id="DDI-PubMed.30420479.s12.e2" text="amodiaquine" /><entity charOffset="107-119" id="DDI-PubMed.30420479.s12.e3" text="dolutegravir" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e0" e2="DDI-PubMed.30420479.s12.e0" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e0" e2="DDI-PubMed.30420479.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e0" e2="DDI-PubMed.30420479.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e0" e2="DDI-PubMed.30420479.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e1" e2="DDI-PubMed.30420479.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e1" e2="DDI-PubMed.30420479.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e1" e2="DDI-PubMed.30420479.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e2" e2="DDI-PubMed.30420479.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30420479.s12.e2" e2="DDI-PubMed.30420479.s12.e3" /></sentence><sentence text=" (This study has been registered at ClinicalTrials" /><sentence text="gov under identifier NCT02242799" /><sentence text=")" /><sentence text="" /></document>